HaifengHuang

Partner

香港 + 852.2526.6895 北京 + 86.10.5866.1111

Connect:

共有

Haifeng Huang leads the Firm's Greater China intellectual property practice and has more than 20 years of experience in cross-border disputes and transactional matters. He is regularly called upon to lead teams and advise clients on their complex business disputes with high-technology components and intellectual property matters involving patents, trademarks, copyrights, trade secrets, unfair competition, antitrust, and technology licenses.

Haifeng has successfully guided representations in high-stakes litigation for many of the world's leading companies in a diverse range of industries, including software and systems, semiconductors, microelectronics, telecommunications, robotics, pharmaceuticals, medical devices, biotechnology, textiles, chemicals, optics, consumer products, and heavy machinery.

He also manages due diligence and transactions and negotiates agreements involving the acquisition, license, and commercialization of intellectual property assets, including research and development (R&D) collaborations, sponsored research, joint development, clinical trials, cross-licensing, strategic alliance, manufacturing, distribution, consulting, and software services.

Haifeng was endorsed by clients and peers in Chambers Global as being "strategic, very reliable and trustworthy" and having a "top-notch IP practice" in China. The WTR 1000 also described him as "one of the country's most seasoned litigators, with a history of representing large U.S. and Chinese concerns in high-stakes disputes."

Haifeng is a Fellow of the Chartered Institute of Arbitrators (FCIArb). He is a member of Harvard Law School's Leadership Council and has also served as a council member for the China Intellectual Property Law Society. He has been an instructor at Renmin University of China Law School's Juris Master Program and has taught advanced courses at the University of Hong Kong.

担当案件

  • NXP defends multi-jurisdiction patent infringement suits involving RFID technologyJones Day represents NXP U.S.A. Inc. against a competitor in a global patent dispute involving more than 50 patents.
  • Hikvision USA secures final judgment and dismissal with prejudice of patent infringement complaint in N.D. TexasJones Day secured a final judgment and dismissal with prejudice for our client Hikvision USA, Inc. in a patent infringement case filed in the Northern District of Texas.
  • Tineco prevails in ITC patent infringement dispute with Bissell over wet-dry surface cleaning devicesJones Day successfully represented Tineco Intelligent Technology Co., Ltd. as respondent in an ITC Section 337 investigation filed by complainants Bissell Inc. and Bissell Homecare Inc. ("Bissell") relating to wet-dry surface cleaning devices.
  • Wybotics secures voluntary dismissal from ITC investigation involving robotic pool cleanersJones Day successfully represented respondent Wybotics Co., Ltd., a manufacturer of robotic pool cleaners, in a Section 337 patent infringement Investigation before the International Trade Commission (ITC).
  • Incyte grants rights to CMS for ruxolitnib cream in China and Southeast AsiaJones Day represented Incyte Corporation in its Collaboration and License Agreement with CMS Aesthetics Limited for the development and commercialization of ruxolitinib cream, a novel cream formulation of Incyte’s selective JAK inhibitor ruxolitinib, for the treatment of autoimmune and inflammatory dermatologic diseases in Greater China and certain countries in Southeast Asia. 
  • Stonepeak forms strategic logistics investment partnership with EqualbaseJones Day represented Stonepeak, a leading U.S.-based alternative investment firm specializing in infrastructure and real assets, in connection with the formation of a Pan-Asia logistics real estate platform in partnership with Equalbase, a development, project, and asset manager specializing in industrial real estate assets in Asia.
  • Velodyne defeats trade secret misappropriation claims at ITC and District CourtJones Day successfully defended leading lidar developer Velodyne Lidar USA, Inc. against trade secret misappropriation claims in the International Trade Commission and U.S. District Court for the Northern District of California, resulting in Complainant voluntarily withdrawing its Complaint and terminating the ITC investigation, and dismissing its district court claims with prejudice.
  • NXP sues Impinj for infringing six patents relating to RFID and wafer-layout technologyJones Day is representing NXP USA, Inc. and NXP B.V. in their enforcement of six radio frequency identification ("RFID") and wafer-layout patents against Impinj, Inc.
  • Hikvision successfully dismisses patent suit involving security systemsJones Day successfully represented Hikvision USA Inc. in dismissing claims of patent infringement in a case brought by Richman Technology Corp. in the Central District of California.
  • Hikvision successfully dismisses patent suit involving body camera technologyJones Day obtained a complete dismissal for defendant Hikvision USA Inc. of a patent infringement lawsuit brought by Stormborn Technologies LLC in the Central District of California.
  • Qualcomm achieves global settlement with AppleJones Day represented Qualcomm Incorporated against Apple Inc. and four contract manufacturers of Apple devices in a lawsuit involving claims for breach of contract and violations of federal antitrust laws and the California Unfair Competition Law.
  • Hikvision resolves patent infringement action relating to surveillance camera devicesJones Day successfully represented Hangzhou Hikvision Digital Technology Co., Ltd. in a patent infringement action relating to remote control surveillance camera devices.
  • Qualcomm enforces patents against Chinese phone manufacturer and distributorJones Day represented Qualcomm Incorporated in the litigation of 17 cases in the Beijing and Shanghai Intellectual Property Courts against a Chinese phone manufacturer and distributor asserting patents concerning radio frequency transceivers, device structures, and other mobile phone technology.
  • Multinational company releases web and cloud-connected video camera to U.S. marketJones Day is advising a multinational video surveillance company related to its U.S. release of an internet-connected audio/video recording device and associated cloud storage service.
  • Hikvision USA wins dismissal with prejudice in multi-defendant patent infringement suitJones Day successfully obtained a voluntary dismissal with prejudice and award of costs on behalf of Hikvision USA, Inc. in a patent infringement case relating to security surveillance technology.
  • High Road Capital acquires York WallcoveringsJones Day advised High Road Capital Partners in connection with the acquisition and related financing of York Wallcoverings Inc., a manufacturer of wallpaper, borders, murals, and RoomMates peel-and-stick removable and reusable wall decals.
  • Riverside completes sale of Baby Jogger Holdings to Newell RubbermaidJones Day represented The Riverside Company in connection with its sale of Baby Jogger Holdings, Inc., a leading designer and marketer of branded infant and juvenile products focused on premium and activity strollers and related accessories, to Newell Rubbermaid, a worldwide marketer of consumer and commercial products with a portfolio of well-known brands.
  • Lesso America defends use of LESSO trademarkChina Lesso Group Holdings Limited/Lesso America retained Jones Day to defend it against claims of trademark infringement brought by Lasco Fittings in the United States District Court for the Central District of California.
  • Australian heavy engineering equipment manufacturer pursues patent invalidationJones Day is conducting patent analysis and due diligence and invalidating five Chinese patents hijacked from Australian heavy engineering equipment manufacturer.
  • European multinational pharmaceutical company collaborates on research in ChinaJones Day devised the contractual and IP structure for ensuring full protection of inventions and know-how developed by a Multinational Pharmaceutical company during the course of pharmaceutical and biotech research collaborations with universities and research institutes in China.
    •

    March 2024 Alert

    China Finalizes Provisions on Cross-Border Data Transfer

    February 2023 Video

    JONES DAY PRESENTS®: The Challenges of Defending Trade Secrets in China

    December 2022 White Paper

    Rising Global Regulation for Artificial Intelligence

    May 2022 Commentary

    Trademark Revocation Actions for Non-Use: Who Bears the Burden?

    March 2022 Commentary

    Which AI Components Are Copyright Protectable and Which Are Not?

    September 2021 Commentary

    Patent Linkage and Article 76 Proceedings in China: A Litigator's Perspective

    August 2021 Commentary

    China's New Data Security Law Restricts Cross-Border Transfers of All Data to Foreign Authorities

    August 2021 White Paper

    2021 Mid-Year Review: Key Global Trade Secret Developments

    June 2021 Commentary

    Chinese Court Enforces Mandatory Licensing for "Essential Facility" Patents in Antitrust Case

    June 2021 Reprint

    China Trade Secret Developments Bring Certainty For U.S. Cos. (Law360)
    インサイト一覧

    出版物情報

    • 2022
      Uncovering Trade Secrets in China: An Empirical Study of Civil Litigation from 2010 to 2020; Journal of Intellectual Property Law & Practice, Volume 17, Issue 9, 2022, Oxford University Press

    講演

    • October 19, 2021
      Trade Secret Enforcement in Greater China: Past Data and Recent Developments
    • October 7, 2021
      Protection of Trademarks and Intellectual Property in China
    • July 21, 2021
      How to Protect Your Innovative Drugs Under China's Hatch-Waxman Act
    • January 18, 2016
      Fee Shifting Strategies for Patent Troll Litigation and IP Review in M&A Transactions
    • 2016年1月18日
      知识产权研讨会——专利流氓诉讼的费用转移策略与并购交易中的知识产权审查
    • 2016年1月18日
      知識產權研討會——專利流氓訴訟的費用轉移策略與併購交易中的知識產權審查
    • October 25, 2012
      China Inbound Seminar: New Challenges and Opportunities for Foreign Investments in China
    • 2012年10月25日
      在华投资研讨会：外商对华投资新的挑战和机遇
    • 2012年10月23日
      生命科学法律剧
    • October 23, 2012
      Life Science Legal Drama - "Mr. Big in Wonderland"
    • May 16, 2012
      Demystifying Well-known Mark Recognition in China
    • April 13, 2012
      Strategies of Defending Trade Secret Lawsuits in China and the US
    • February 13, 2012
      Ten Common Mistakes to Avoid while Protecting Your IP Rights in China
    • September 21, 2011
      Managing Intellectual Property in China - Realities and Pitfalls
    • September 9, 2011
      Arbitration Clauses in Commercial Agreements - Do you know what you're signing up to?
    • April 16, 2011
      Walking on Eggshells: Dealing with IP and Regulatory Issues in China
    • April 6, 2011
      IP Due Diligence
    • November 23, 2010
      Technology Transfer in China
    • November 22, 2010
      Protecting Your Brands in China: Challenges and Opportunities
    • April 25, 2008
      Regulatory Roadmap for Pharmaceutical Innovations in China

    送信する前の注意事項：

    www.jonesday.comに掲載されている情報は、一般的な使用を目的としており、法的アドバイスを目的としたものではありません。このEmailを送信することにより、弁護士を含む専門家・依頼者の関係を構築することを意図するものではなく、このEmailの受領はそのような関係を構築するものではありません。当事務所に送信されたいかなる情報も、業務委託契約を結ばない限り、弁護士等が依頼者に対して守秘義務を負う機密事項として取り扱われることはありません。このEmailの送信者は以上の注意事項の内容を読み、理解したものと判断します。